Craig Martin

Company: University of Massachusetts Amherst

Job title: Professor

Seminars:

Roundtable Session – Discussion Of Current Assays, Metrics & Prospects For The Future 9:30 am

What are the limitations of current assays? Are current assays sufficient for the wide range of RNA therapeutics into the future?Read more

day: Conference Day Two

Roundtable Discussion: Innovations in Addressing Purification Challenges to Produce High Quality mRNA Therapeutics & Vaccines 11:00 am

What the best methods for mRNA purification?  Do they change with scale?  Does a two-step purification significantly improve purity? Under what circumstances (volume, throughput) do the continuous purification methods offer significant advantage? For dsRNA: What are the best approaches to reduce dsRNA during IVT Which forms are dominant and which forms are immunogenic What are…Read more

day: Conference Day One

Discussing Optimal Documentation Curation & Management for Efficient Creation & Reproducibility of Your QC Testing to Enhance Development Processes & Regulatory Compliance for Your mRNA Therapeutics 1:31 pm

As we navigate the intricacies of developing and producing mRNA-based treatments, the accuracy, accessibility, and compliance of our documentation play a pivotal role in ensuring regulatory adherence, reproducibility, and ultimately, the efficacy of our therapeutic interventions. Join us as we delve into the strategies, best practices, and innovative approaches to curate and manage documentation effectively,…Read more

day: Pre-Conference Day